The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...

The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over ...

The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...